Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection

Journal of Hepatology

Volumn 52, Issue 2, 2010, Pages 183-190

  Crotta, Stefania ^a   Brazzoli, Michela ^a   Piccioli, Diego ^a   Valiante, Nicholas M ^b   Wack, Andreas ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b Department of Immunology Novartis Vaccines and Diagnostics ^*  (United States)

Author keywords

Chronic infection; HCV E2 glycoprotein; IFN ; IL 8; Natural killer cells; Tetraspanin

Indexed keywords

CD81 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN E2; INTERLEUKIN 12; INTERLEUKIN 8; VIRUS ENVELOPE PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; EFFECTOR CELL; GENETIC VARIABILITY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NATURAL KILLER CELL; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRAL GENETICS; VIRION; VIRUS INFECTIVITY; VIRUS PARTICLE;

ANTIGENS, CD; CELLS, CULTURED; CROSS-LINKING REAGENTS; CYTOKINES; HEPACIVIRUS; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-8; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; VIRAL ENVELOPE PROTEINS;

EID: 75549090719     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.11.003     Document Type: Article

References (34)

1. Dustin L.B., and Rice C.M. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol 25 (2007) 71-99
2. Bigger C.B., Brasky K.M., and Lanford R.E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 75 (2001) 7059-7066
3. Bigger C.B., Guerra B., Brasky K.M., Hubbard G., Beard M.R., Luxon B.A., et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 78 (2004) 13779-13792
4. Su A.I., Pezacki J.P., Wodicka L., Brideau A.D., Supekova L., Thimme R., et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 99 (2002) 15669-15674
5. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 102 (2005) 2992-2997
6. Foy E., Li K., Wang C., Sumpter Jr. R., Ikeda M., Lemon S.M., et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 (2003) 1145-1148
7. Taylor D.R., Shi S.T., Romano P.R., Barber G.N., and Lai M.M. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285 (1999) 107-110
8. Gale Jr. M., Blakely C.M., Kwieciszewski B., Tan S.L., Dossett M., Tang N.M., et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18 (1998) 5208-5218
9. Geiss G.K., Carter V.S., He Y., Kwieciszewski B.K., Holzman T., Korth M.J., et al. Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J Virol 77 (2003) 6367-6375
10. Polyak S.J., Khabar K.S., Paschal D.M., Ezelle H.J., Duverlie G., Barber G.N., et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 75 (2001) 6095-6106
11. Khabar K.S., Al-Zoghaibi F., Al-Ahdal M.N., Murayama T., Dhalla M., Mukaida N., et al. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J Exp Med 186 (1997) 1077-1085
12. Koo B.C., McPoland P., Wagoner J.P., Kane O.J., Lohmann V., and Polyak S.J. Relationships between hepatitis C virus replication and CXCL-8 production in vitro. J Virol 80 (2006) 7885-7893
13. Polyak S.J., Khabar K.S., Rezeiq M., and Gretch D.R. Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 75 (2001) 6209-6211
14. Newman K.C., and Riley E.M. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 7 (2007) 279-291
15. Khakoo S.I., Thio C.L., Martin M.P., Brooks C.R., Gao X., Astemborski J., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 (2004) 872-874
16. Crotta S., Stilla A., Wack A., D'Andrea A., Nuti S., D'Oro U., et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195 (2002) 35-41
17. Tseng C.T., and Klimpel G.R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195 (2002) 43-49
18. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., et al. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
19. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11 (2005) 791-796
20. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102 (2005) 9294-9299
21. Yoon J.C., Shiina M., Ahlenstiel G., and Rehermann B. Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology 49 (2009) 12-21
22. Frese M., Schwarzle V., Barth K., Krieger N., Lohmann V., Mihm S., et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35 (2002) 694-703
23. Rosa D., Saletti G., De Gregorio E., Zorat F., Comar C., D'Oro U., et al. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for HCV-associated B-lymphocyte disorders. Proc Natl Acad Sci USA 102 (2005) 18544-18549
24. Heile J.M., Fong Y.L., Rosa D., Berger K., Saletti G., Campagnoli S., et al. Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates. J Virol 74 (2000) 6885-6892
25. Perussia B., Ramoni C., Anegon I., Cuturi M.C., Faust J., and Trinchieri G. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat Immun Cell Growth Regul 6 (1987) 171-188
26. Wack A., Soldaini E., Tseng C., Nuti S., Klimpel G., and Abrignani S. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur J Immunol 31 (2001) 166-175
27. Zhu Q., Oei Y., Mendel D.B., Garrett E.N., Patawaran M.B., Hollenbach P.W., et al. Novel robust hepatitis C virus mouse efficacy model. Antimicrob Agents Chemother 50 (2006) 3260-3268
28. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., and Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 (1999) 110-113
29. Marukian S., Jones C.T., Andrus L., Evans M.J., Ritola K.D., Charles E.D., et al. Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48 (2008) 1843-1850
30. Orange J.S., and Biron C.A. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 156 (1996) 1138-1142
31. Monteiro J.M., Harvey C., and Trinchieri G. Role of interleukin-12 in primary influenza virus infection. J Virol 72 (1998) 4825-4831
32. Krug A., French A.R., Barchet W., Fischer J.A., Dzionek A., Pingel J.T., et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21 (2004) 107-119
33. Ludwig I.S., Lekkerkerker A.N., Depla E., Bosman F., Musters R.J., Depraetere S., et al. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J Virol 78 (2004) 8322-8332
34. Crotta S., Ronconi V., Ulivieri C., Baldari C.T., Valiante N.M., Abrignani S., et al. Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells. Eur J Immunol 36 (2006) 919-929